YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.

Yap TA, Kwiatkowski DJ, Dagogo-Jack I, Offin M, Zauderer MG, Kratzke R, Desai J, Body A, Millward M, Tolcher AW, Raghav KPS, Thurston A, Post L, Dorr FA, Tang TT, Li Y, Sharma N, Kindler HL

Open source

DOI
10.1038/s41591-025-04029-3
Published
2025 Dec
Container
Nature medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-04029-3,
  title = {YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.},
  author = {Yap TA and Kwiatkowski DJ and Dagogo-Jack I and Offin M and Zauderer MG and Kratzke R and Desai J and Body A and Millward M and Tolcher AW and Raghav KPS and Thurston A and Post L and Dorr FA and Tang TT and Li Y and Sharma N and Kindler HL},
  year = {2025},
  journal = {Nature medicine},
  doi = {10.1038/s41591-025-04029-3},
  url = {https://doi.org/10.1038/s41591-025-04029-3}
}

RIS

TY  - JOUR
TI  - YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.
AU  - Yap TA
AU  - Kwiatkowski DJ
AU  - Dagogo-Jack I
AU  - Offin M
AU  - Zauderer MG
AU  - Kratzke R
AU  - Desai J
AU  - Body A
AU  - Millward M
AU  - Tolcher AW
AU  - Raghav KPS
AU  - Thurston A
AU  - Post L
AU  - Dorr FA
AU  - Tang TT
AU  - Li Y
AU  - Sharma N
AU  - Kindler HL
PY  - 2025
JO  - Nature medicine
DO  - 10.1038/s41591-025-04029-3
UR  - https://doi.org/10.1038/s41591-025-04029-3
ER  - 

APA

TA, Y., DJ, K., I, D., M, O., MG, Z., R, K., J, D., A, B., M, M., AW, T., KPS, R., A, T., L, P., FA, D., TT, T., Y, L., N, S., & HL, K. (2025). YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.. Nature medicine. https://doi.org/10.1038/s41591-025-04029-3

Source records